Dallas, TX 7/12/2010 4:41:12 AM
News / Business

LBSRE and CPRX are the Stocks to Watch for July 12th from OTCPicks.com

OTCPicks.com Presents Tomorrow’s Stocks to Watch

Dallas, TX - The Publisher of Daily OTC Stocks Newsletter (http://www.otcpicks.com/hotpicks.htm ) and Free Red Hot Stock Picks presents the following penny stocks to watch tomorrow: Liberty Star Uranium & Metals Corp. (OTCBB: LBSR) and Catalyst Pharmaceutical Partners Inc. (Nasdaq: CPRX).

LIBERTY STAR URANIUM & METALS CORPORATION (OTCBB: LBSRE) "Up 140.00% on Friday"

Liberty Star Uranium & Metals Corp. engages in the acquisition and exploration of mineral properties in Arizona and Alaska. It holds interests in North Pipes Super Project with 1,757 Federal lode mining claims in northern Arizona on the Arizona Strip; Big Chunk Super Project with 707 mineral claims in the Iliamna region of southwestern Alaska; and Bonanza Hills Project with 56 mineral claims in the Iliamna region of southwestern Alaska. The company focuses on the exploration of uranium, copper, gold, molybdenum, silver, and zinc properties. Liberty Star Uranium & Metals Corp. was founded in 2001 and is based in Tucson, Arizona.

CATALYST PHARMACEUTICAL PARTNERS (NASDAQ: CPRX) "Up 46.67% on Friday"

Catalyst Pharmaceutical Partners, Inc. is a biopharmaceutical company focused on the development and commercialization of prescription drugs for the treatment of addiction and obsessive-compulsive disorders. The Company has obtained from Brookhaven National Laboratory an exclusive worldwide license for nine patents in the United States relating to the right to use vigabatrin to treat a wide variety of substance addictions and obsessive-compulsive disorders. Catalyst has also been granted rights to Brookhaven's vigabatrin-related foreign patents or patents pending in more than 30 countries. The Company's initial product candidate based on vigabatrin is CPP-109. CPP-109 has been granted "Fast Track" status by the U.S. Food & Drug Administration (FDA) for the treatment of cocaine addiction. This indicates that the FDA has recognized that CPP-109 is intended for the treatment of a serious or life-threatening condition for which there is no effective treatment and which demonstrates the potential to address unmet medical needs.

The stocks presented above are available in OTCPicks.com's Free Daily Email Newsletter. For daily penny stock alerts go to  http://www.otcpicks.com/hotpicks.htm 

Get the latest updates via Twitter at www.twitter.com/otcpicks or through Facebook - www.facebook.com/otcpicks.

Disclosure: OTCPicks has not been compensated by any of the companies covered in this release.